1s1 Energy is focused on developing innovative material technology for PEM water electrolysis systems, enabling affordable green hydrogen production. Their proprietary boron-based chemistry allows for higher efficiency with 20-30% lower electricity use and 50% lower capital expenditure compared to industry norms. The company emphasizes in-house manufacturing for supply chain control and offers environmentally friendly components. With a mission to accelerate decarbonization, 1s1 Energy has established collaborations with notable organizations and has received multiple patents for its technology, positioning itself as a leader in the green hydrogen market.

Abtrace is a healthcare technology company that provides an automated, self-learning care system designed to enhance patient monitoring and management. Their Proactive Monitoring tool integrates with EMIS and Systm One, enabling healthcare practices to optimize resources, improve patient safety, and maximize revenue through automated recall processes and real-time dashboards. With over 250 practices and 3 million patients covered, Abtrace differentiates itself by focusing on predictive, preventative, and proactive care, aiming to keep patients healthy and out of the hospital.

ANNEA is a modular AI-based platform that enhances the reliability and efficiency of renewable energy assets through predictive maintenance and performance optimization. The platform is designed to minimize downtime, reduce operational costs by 10% to 50%, and increase energy production by 5% to 15%. With a focus on power producers, service providers, and original equipment manufacturers, ANNEA leverages advanced predictive technologies and data-driven insights to ensure optimal performance of assets like wind turbines and solar farms. The company positions itself as a leader in the renewable energy sector, committed to driving sustainability and operational excellence.

B’ZEOS offers seaweed-based packaging solutions to industries looking for sustainable alternatives and a way to decarbonize their industry. B’ZEOS is a technology-based start-up that focuses on material development based on seaweed, and our innovation lies within the material formulation, which is converted into tailored packaging solutions.

Biographica is a biotechnology company leveraging machine learning, graph theory, and genomics to accelerate gene discovery in agriculture. The company differentiates itself through its expertise in graph-based biological modeling and a strong team with backgrounds in computational genomics and bioinformatics. With partnerships in the agricultural sector and backing from notable venture capital firms, Biographica is positioned to make significant advancements in crop gene-editing technologies, aiming to enhance target discovery methods for improved agricultural outcomes.

Circuit Leap is focused on leveraging AI and distributed computing to revolutionize the design process of analog integrated circuits (ICs). By integrating advanced technologies, the company aims to enhance efficiency and innovation in the semiconductor industry, positioning itself as a leader in transforming traditional design methodologies. Their unique approach differentiates them in a competitive market, targeting a growing demand for smarter and more efficient IC design solutions.

Codacy is an automated code review tool founded in 2012 that helps developers improve code quality and security efficiently. It offers a comprehensive toolbox for clean code, secure code, test coverage, and engineering performance, integrating seamlessly across the software development lifecycle. With a focus on automation and AI-driven suggestions, Codacy enables teams to monitor coding standards, find security issues, and enhance overall engineering performance. The company has reached over 600,000 developers and is SOC 2 Type 2 certified, positioning itself as a leader in the code quality and security market.

The place for legal work.Equall is building artificial legal intelligence (ALI) through foundational language models for law, specialized AI systems and end-to-end workflows for practice and enterprise

Faber is a Lisbon-based venture capital firm that invests in early-stage startups focused on deep tech, particularly in applied science, digital transformation, and climate technologies. The firm supports entrepreneurs with funding up to €2.5M and a robust advisory network, helping them scale their innovations globally. Faber's unique approach combines entrepreneurial experience with scientific expertise, positioning it as a key player in Southern Europe’s venture capital landscape. The firm has a track record of investing in transformative companies and is actively involved in nurturing the next generation of science-driven founders.

Hefring Marine is an Icelandic maritime technology leader specializing in AI-driven solutions for vessel safety and performance. Founded in 2018, the company offers the Intelligent Marine Assistance System (IMAS™), which utilizes AI, sensor data, and edge computing to provide real-time insights that enhance vessel safety, optimize fuel efficiency, and promote sustainable operations. With over 370,000 nautical miles covered and 32,000 trips completed, Hefring Marine is transforming marine operations, making them safer and more efficient. The company is committed to reducing environmental impact and improving operational costs for vessel operators and fleet managers.

Hole19 owns the golfers journey from start to finish. Before the round we help golfers discover golf courses & book tee times; during the round they can plan & track rounds with GPS and scoring; after the round we help golfers review performance and connect with like-minded golfers. Want to promote your product or brand to a community of over 1.2M golfers around the world that are passionate about golf? Reach out to our partnership team via partners@hole19golf.com

iLoF is an innovative company focused on personalized medicine, utilizing a cloud-based library of optical fingerprints powered by photonics and AI for non-invasive drug discovery. Their platform offers significant cost savings and time reductions in clinical trial screenings, while improving patient outcomes by providing a more qualified candidate pool. With a strong emphasis on Alzheimer's disease, they are expanding their capabilities to other diseases, positioning themselves as a leader in the digital health space.